In contrast, in cachexia, increased lipolysis is driven primarily by tumour-derived factors (e.g., IL-6, TNF-α, and PTHrP) and systemic inflammation, leading to a net loss of fat mass rather than fat accumulation (Joshi & Patel 2022 [164]). This evidence concerns the gene IL6 and Cachexia.